Ella Korets-Smith
Corporate Officer/Principal bei ANTIBE THERAPEUTICS INC.
Profil
Ella Korets-Smith is the founder and the Chief Strategy Officer at Virica Biotech, Inc., which was founded in 2018.
She is currently the Vice President-Business Development at Antibe Therapeutics, Inc. Ella's former positions include being the Chief Executive Officer & Director at ToHealth Ltd., Director-Business Development at IMV, Inc., Global Brand Manager at Nordion (Canada), Inc., and Vice President-Business Development at Advanced Proteome Therapeutics Corp.
Ella holds an MBA from Dalhousie University (conferred in 2008) and a graduate degree from the University of Toronto (conferred in 2004).
Aktive Positionen von Ella Korets-Smith
| Unternehmen | Position | Beginn |
|---|---|---|
| ANTIBE THERAPEUTICS INC. | Corporate Officer/Principal | - |
Virica Biotech, Inc.
 Virica Biotech, Inc. Pharmaceuticals: MajorHealth Technology Virica Biotech, Inc. is a Canadian company that specializes in viral medicines, including gene therapies, vaccines, and oncolytic viruses. The company is based in Ottawa, Canada and was founded in 2018 by Ella Korets-Smith and Jean-Simon Diallo. The company has developed a new product category of viral sensitizers (VSE™) that removes the barriers to manufacturing effective viral medicines at scale. The company's purpose is to realize the promise of viral medicines and extend the horizons of human healthcare. Jean-Simon Diallo has been the CEO since 2018. | Founder | 01.01.2018 |
Ehemalige bekannte Positionen von Ella Korets-Smith
| Unternehmen | Position | Ende |
|---|---|---|
ToHealth Ltd.
 ToHealth Ltd. Medical/Nursing ServicesHealth Services ToHealth Ltd. provides health and wellbeing services. The private company is based in London, UK. The CEO of the British company is Robin Skinner. | Chief Executive Officer | - |
| NORDION INC | Corporate Officer/Principal | - |
| ADVANCED PROTEOME THERAPEUTICS CORPORATION | Corporate Officer/Principal | - |
| IMV INC. | Corporate Officer/Principal | - |
Ausbildung von Ella Korets-Smith
| Dalhousie University | Masters Business Admin |
| University of Toronto | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| ADVANCED PROTEOME THERAPEUTICS CORPORATION | Health Technology |
| IMV INC. | Health Technology |
| ANTIBE THERAPEUTICS INC. | Health Technology |
| Private Unternehmen | 3 |
|---|---|
Nordion (Canada), Inc.
 Nordion (Canada), Inc. Pharmaceuticals: MajorHealth Technology Nordion (Canada), Inc. provides drug discovery and development research services. It specializes in health science, gamma irradiation, radiopharmaceutical, gamma sterilization, medical isotopes, and production irradiators. The company was founded in 1946 and is headquartered in Ottawa, Canada. | Health Technology |
ToHealth Ltd.
ToHealth Ltd. Medical/Nursing ServicesHealth Services ToHealth Ltd. provides health and wellbeing services. The private company is based in London, UK. The CEO of the British company is Robin Skinner. | Health Services |
Virica Biotech, Inc.
Virica Biotech, Inc. Pharmaceuticals: MajorHealth Technology Virica Biotech, Inc. is a Canadian company that specializes in viral medicines, including gene therapies, vaccines, and oncolytic viruses. The company is based in Ottawa, Canada and was founded in 2018 by Ella Korets-Smith and Jean-Simon Diallo. The company has developed a new product category of viral sensitizers (VSE™) that removes the barriers to manufacturing effective viral medicines at scale. The company's purpose is to realize the promise of viral medicines and extend the horizons of human healthcare. Jean-Simon Diallo has been the CEO since 2018. | Health Technology |
